Analysis of the SYSDIET Healthy Nordic Diet randomized trial based on metabolic profiling reveal beneficial effects on glucose metabolism and blood lipids

Gespeichert in:
Bibliographische Detailangaben
Titel: Analysis of the SYSDIET Healthy Nordic Diet randomized trial based on metabolic profiling reveal beneficial effects on glucose metabolism and blood lipids
Autoren: Gürdeniz, Gözde, Uusitupa, Matti, Hermansen, Kjeld, Savolainen, Markku J., Schwab, Ursula, Kolehmainen, Marjukka, Brader, Lea, Cloetens, Lieselotte, Herzig, Karl Heinz, Hukkanen, Janne, Rosqvist, Fredrik, Ulven, Stine Marie, Gunnarsdóttir, Ingibjörg, Thorsdottir, Inga, Orešič, Matej, Poutanen, Kaisa S., Risérus, Ulf, Åkesson, Björn, Dragsted, Lars Ove
Quelle: Gürdeniz, G, Uusitupa, M, Hermansen, K, Savolainen, M J, Schwab, U, Kolehmainen, M, Brader, L J, Cloetens, L, Herzig, K-H, Hukkanen, J, Rosqvist, F, Ulven, S M, Gunnarsdóttir, I, Thorsdottir, I, Orešič, M, Poutanen, K S, Risérus, U, Åkesson, B & Dragsted, L O 2022, ' Analysis of the SYSDIET Healthy Nordic Diet randomized trial based on metabolic profiling reveal beneficial effects on glucose metabolism and blood lipids ', Clinical Nutrition, vol. 41, no. 2, pp. 441-451 . https://doi.org/10.1016/j.clnu.2021.12.031
Gürdeniz, G, Uusitupa, M, Hermansen, K, Savolainen, M J, Schwab, U, Kolehmainen, M, Brader, L, Cloetens, L, Herzig, K H, Hukkanen, J, Rosqvist, F, Ulven, S M, Gunnarsdóttir, I, Thorsdottir, I, Oresic, M, Poutanen, K S, Risérus, U, Åkesson, B & Dragsted, L O 2022, 'Analysis of the SYSDIET Healthy Nordic Diet randomized trial based on metabolic profiling reveal beneficial effects on glucose metabolism and blood lipids', Clinical Nutrition, vol. 41, no. 2, pp. 441-451. https://doi.org/10.1016/j.clnu.2021.12.031
Verlagsinformationen: Elsevier BV, 2022.
Publikationsjahr: 2022
Schlagwörter: Blood Glucose, Male, 0301 basic medicine, Fasting/blood, Overweight/complications, Glucose and lipid metabolism, Eating, Healthy Nordic diet, Faculty of Science, Randomized Controlled Trials as Topic, Eating/physiology, Metabolic Syndrome, 2. Zero hunger, Principal Component Analysis, 0303 health sciences, Nutrition and Dietetics, LC–MS metabolomics, ta3141, Fasting, Middle Aged, Lipids, 6. Clean water, 3. Good health, Näringslära, Triglycerides/blood, Randomized controlled trial, Inflammation Mediators/blood, Area Under Curve, name=Faculty of Science, Female, Diet, Healthy, Inflammation Mediators, Näringslära och dietkunskap, Lipoproteins, Scandinavian and Nordic Countries, ta3111, 03 medical and health sciences, Lipoproteins/blood, Metabolomics/methods, Humans, Metabolomics, Blood Glucose/metabolism, Lipids/blood, Cardiometabolic Risk Factors, ta3121, Plasma metabolite scores, Overweight, LC-MS metabolomics, Metabolic Syndrome/complications, Nutrition Assessment, Biomarkers/blood, Diet, Healthy/methods, Biomarkers
Beschreibung: Intake assessment in multicenter trials is challenging, yet important for accurate outcome evaluation. The present study aimed to characterize a multicenter randomized controlled trial with a healthy Nordic diet (HND) compared to a Control diet (CD) by plasma and urine metabolic profiles and to associate them with cardiometabolic markers.During 18-24 weeks of intervention, 200 participants with metabolic syndrome were advised at six centres to eat either HND (e.g. whole-grain products, berries, rapeseed oil, fish and low-fat dairy) or CD while being weight stable. Of these 166/159 completers delivered blood/urine samples. Metabolic profiles of fasting plasma and 24 h pooled urine were analysed to identify characteristic diet-related patterns. Principal components analysis (PCA) scores (i.e. PC1 and PC2 scores) were used to test their combined effect on blood glucose response (primary endpoint), serum lipoproteins, triglycerides, and inflammatory markers.The profiles distinguished HND and CD with AUC of 0.96 ± 0.03 and 0.93 ± 0.02 for plasma and urine, respectively, with limited heterogeneity between centers, reflecting markers of key foods. Markers of fish, whole grain and polyunsaturated lipids characterized HND, while CD was reflected by lipids containing palmitoleic acid. The PC1 scores of plasma metabolites characterizing the intervention is associated with HDL (β = 0.05; 95% CI: 0.02, 0.08; P = 0.001) and triglycerides (β = -0.06; 95% CI: -0.09, -0.03; P
Publikationsart: Article
Dateibeschreibung: application/pdf
Sprache: English
ISSN: 0261-5614
DOI: 10.1016/j.clnu.2021.12.031
Zugangs-URL: http://www.clinicalnutritionjournal.com/article/S0261561421005963/pdf
https://pubmed.ncbi.nlm.nih.gov/35007813
https://cris.vtt.fi/en/publications/7f5e9df4-9375-40eb-a062-4676193c74ee
https://doi.org/10.1016/j.clnu.2021.12.031
http://hdl.handle.net/10852/98532
https://doi.org/10.1016/j.clnu.2021.12.031
http://urn.fi/urn:nbn:fi-fe2022061647006
https://curis.ku.dk/ws/files/289168321/Gurdeniz_et_al_Clinical_Nutrition_2022_Vol_11_2_441_451.pdf
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-469771
http://www.scopus.com/inward/record.url?scp=85122434050&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/cee2ba64-80f1-44a4-8cad-b4b1753af5c9
https://doi.org/10.1016/j.clnu.2021.12.031
Rights: CC BY
Dokumentencode: edsair.doi.dedup.....831e24d84a7799f66ef5c2ad3c32aed9
Datenbank: OpenAIRE
Beschreibung
Abstract:Intake assessment in multicenter trials is challenging, yet important for accurate outcome evaluation. The present study aimed to characterize a multicenter randomized controlled trial with a healthy Nordic diet (HND) compared to a Control diet (CD) by plasma and urine metabolic profiles and to associate them with cardiometabolic markers.During 18-24 weeks of intervention, 200 participants with metabolic syndrome were advised at six centres to eat either HND (e.g. whole-grain products, berries, rapeseed oil, fish and low-fat dairy) or CD while being weight stable. Of these 166/159 completers delivered blood/urine samples. Metabolic profiles of fasting plasma and 24 h pooled urine were analysed to identify characteristic diet-related patterns. Principal components analysis (PCA) scores (i.e. PC1 and PC2 scores) were used to test their combined effect on blood glucose response (primary endpoint), serum lipoproteins, triglycerides, and inflammatory markers.The profiles distinguished HND and CD with AUC of 0.96 ± 0.03 and 0.93 ± 0.02 for plasma and urine, respectively, with limited heterogeneity between centers, reflecting markers of key foods. Markers of fish, whole grain and polyunsaturated lipids characterized HND, while CD was reflected by lipids containing palmitoleic acid. The PC1 scores of plasma metabolites characterizing the intervention is associated with HDL (β = 0.05; 95% CI: 0.02, 0.08; P = 0.001) and triglycerides (β = -0.06; 95% CI: -0.09, -0.03; P
ISSN:02615614
DOI:10.1016/j.clnu.2021.12.031